Wetherby Asset Management Inc. decreased its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 22.4% during the third quarter, Holdings Channel reports. The fund owned 6,406 shares of the company’s stock after selling 1,851 shares during the period. Wetherby Asset Management Inc.’s holdings in Henry Schein were worth $407,000 as of its most recent SEC filing.
Several other hedge funds have also recently bought and sold shares of the business. Vanguard Group Inc. grew its holdings in shares of Henry Schein by 2.4% during the 2nd quarter. Vanguard Group Inc. now owns 16,865,641 shares of the company’s stock worth $1,178,909,000 after acquiring an additional 391,485 shares during the period. Longview Partners Guernsey LTD grew its stake in shares of Henry Schein by 15.8% in the 2nd quarter. Longview Partners Guernsey LTD now owns 15,527,241 shares of the company’s stock worth $1,085,354,000 after buying an additional 2,117,869 shares during the last quarter. Atlanta Capital Management Co. L L C grew its stake in shares of Henry Schein by 0.5% in the 2nd quarter. Atlanta Capital Management Co. L L C now owns 6,343,280 shares of the company’s stock worth $443,395,000 after buying an additional 30,201 shares during the last quarter. JPMorgan Chase & Co. grew its stake in shares of Henry Schein by 9.8% in the 2nd quarter. JPMorgan Chase & Co. now owns 2,664,995 shares of the company’s stock worth $184,285,000 after buying an additional 238,078 shares during the last quarter. Finally, Northern Trust Corp grew its stake in shares of Henry Schein by 1.1% in the 2nd quarter. Northern Trust Corp now owns 1,959,014 shares of the company’s stock worth $136,934,000 after buying an additional 20,415 shares during the last quarter.
HSIC has been the topic of several recent research reports. BidaskClub downgraded Henry Schein from a “hold” rating to a “sell” rating in a research note on Thursday, September 26th. Zacks Investment Research downgraded Henry Schein from a “hold” rating to a “sell” rating and set a $71.00 target price on the stock. in a research note on Wednesday. William Blair downgraded Henry Schein from an “outperform” rating to a “market perform” rating in a research note on Wednesday, August 7th. TheStreet upgraded Henry Schein from a “c+” rating to a “b” rating in a research note on Monday, October 14th. Finally, Barrington Research reiterated a “buy” rating and set a $75.00 target price on shares of Henry Schein in a research note on Wednesday. Six research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have given a buy rating to the company. Henry Schein currently has an average rating of “Hold” and an average target price of $73.50.
NASDAQ HSIC opened at $68.74 on Friday. The business’s fifty day moving average price is $63.06 and its 200-day moving average price is $65.31. The stock has a market capitalization of $10.04 billion, a price-to-earnings ratio of 16.64, a PEG ratio of 2.62 and a beta of 0.85. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.63 and a quick ratio of 0.95. Henry Schein, Inc. has a 1-year low of $56.58 and a 1-year high of $72.81.
Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, November 5th. The company reported $0.90 earnings per share for the quarter, beating the consensus estimate of $0.86 by $0.04. The firm had revenue of $2.51 billion for the quarter, compared to analysts’ expectations of $2.52 billion. Henry Schein had a return on equity of 15.93% and a net margin of 4.66%. The company’s revenue was up 6.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.03 EPS. Equities research analysts anticipate that Henry Schein, Inc. will post 3.45 EPS for the current year.
Henry Schein declared that its board has authorized a stock repurchase plan on Thursday, October 31st that permits the company to buyback $400.00 million in outstanding shares. This buyback authorization permits the company to purchase up to 4.3% of its shares through open market purchases. Shares buyback plans are generally a sign that the company’s board of directors believes its shares are undervalued.
In other news, Vice Chairman James P. Breslawski sold 6,856 shares of the stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $66.96, for a total transaction of $459,077.76. Following the transaction, the insider now directly owns 242,190 shares of the company’s stock, valued at approximately $16,217,042.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Michael S. Ettinger sold 3,671 shares of the stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $66.96, for a total value of $245,810.16. Following the transaction, the senior vice president now directly owns 87,972 shares in the company, valued at $5,890,605.12. The disclosure for this sale can be found here. 1.06% of the stock is owned by corporate insiders.
Henry Schein Profile
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Featured Story: What is a put option?
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.